76 results on '"Vokes, E. E."'
Search Results
2. Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer
3. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
4. Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades
5. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
6. Evidence-based role of bevacizumab in non-small cell lung cancer
7. UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
8. Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck
9. A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers
10. Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels
11. Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma
12. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest
13. Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus
14. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
15. Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck
16. A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer
17. A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer
18. With regard to “Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer” by Oh et al. (AnnOnc 2003; 14: 464–569)
19. Phase II study of flavopiridol in patients with advanced colorectal cancer
20. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary
21. A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain
22. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer
23. A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer
24. Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer
25. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer
26. A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer
27. Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis of Intestinal Toxicity Associated with Irinotecan (CPT-11): Validation of Biliary Index (BI): PIII-38
28. Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.
29. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
30. Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck.
31. Evaluation of neuropathy in patients on suramin treatment.
32. Escalating doses of interferon alpha-2A with cisplatin and concomitant radiotherapy: a phase I study.
33. Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study.
34. Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer.
35. 5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
36. Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study.
37. Serum immunoerythropoietin levels in patients with cancer receiving cisplatin-based chemotherapy.
38. A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer.
39. Chemotherapy-related hemolytic-uremic syndrome after the treatment of head and neck cancer. A case report.
40. 5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer.
41. A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer.
42. A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.
43. Flow cytometry in hairy cell leukemia before and during interferon alfa-2b therapy.
44. Second malignancies in hairy cell leukemia.
45. Interferons and other cytokines in head and neck cancer.
46. Chemotherapy, biologics, and chemoprevention as systemic therapies for head and neck cancer.
47. Chemotherapy and combined modality therapy in head and neck cancer.
48. Chemotherapy in head and neck cancer.
49. Chemotherapeutic and biologic radiation enhancement.
50. Chemotherapy and integrated treatment approaches in head and neck cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.